Silence Therapeutics (SLN) Other Working Capital Changes: 2019-2025
Historic Other Working Capital Changes for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to -$5.3 million.
- Silence Therapeutics' Other Working Capital Changes fell 679.39% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 124.52%. This contributed to the annual value of $457,998 for FY2024, which is 104.44% up from last year.
- As of Q3 2025, Silence Therapeutics' Other Working Capital Changes stood at -$5.3 million, which was down 76.64% from -$3.0 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Working Capital Changes registered a high of $14.3 million during Q3 2023, and its lowest value of -$24.2 million during Q4 2024.
- Moreover, its 3-year median value for Other Working Capital Changes was $592,000 (2025), whereas its average is $709,443.
- Per our database at Business Quant, Silence Therapeutics' Other Working Capital Changes surged by 206.81% in 2022 and then plummeted by 679.39% in 2025.
- MRQ analysis of 5 years shows Silence Therapeutics' Other Working Capital Changes stood at $7.4 million in 2021, then surged by 53.61% to $11.4 million in 2022, then dropped by 0.81% to $11.3 million in 2023, then plummeted by 313.09% to -$24.2 million in 2024, then skyrocketed by 77.93% to -$5.3 million in 2025.
- Its last three reported values are -$5.3 million in Q3 2025, -$3.0 million for Q2 2025, and $592,000 during Q1 2025.